<h1>AI compliance platform for pharma automates GxP mapping but raises liability, validation, audit trail, and data protection concerns</h1> A Bengaluru-based IT company announced an AI-driven compliance assessment platform for the pharmaceutical and life sciences sectors that automates content mapping to external regulations (GxP, FDA, EMA), internal standards and custom rules, produces audit-ready outputs, and supports human review. Legally, the product may reduce regulatory risk by standardizing documentation and detecting noncompliance early, but raises issues including vendor and user liability for AI errors, regulatory acceptance of automated findings, the need for demonstrable audit trails and validation, and data protection and confidentiality obligations when processing sensitive clinical and regulatory materials.